Search details
1.
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Hepatology
; 78(2): 397-415, 2023 08 01.
Article
in English
| MEDLINE | ID: mdl-37386786
Results
1 -
1
de 1
1
Next >
>>